Log inSign up
Ansu Satpathy
1,194 posts
user avatar
Ansu Satpathy
@Satpathology
Professor @Stanford, Investor @Wing_VC Founder @CartographyBio @Immunaitech @Arpelos @SantaAnaBio
satpathylab.com
Joined July 2015
872
Following
4,106
Followers
  • user avatar
    Ansu Satpathy
    @Satpathology
    Dec 1, 2023
    20 years ago, I sent ~100 cold emails to PIs asking to work in their labs with no immunology experience. Diane was the only one who said yes. I drove across the country and stayed in youth hostels so I could work in her lab, and it started my career. Congratulations, Diane.
    user avatar
    Miriam Merad, MD, PhD
    @MiriamMerad
    Dec 1, 2023
    Celebrating the inaugural awardee of the Menarini Prize for outstanding woman Immunologist : Pr. Diane Mathis ⁦@harvardmed⁩ - congratulation Diane
    159K
  • user avatar
    Ansu Satpathy
    @Satpathology
    Jan 14, 2022
    To me, a major problem is the viewpoint that there is/should be a one-way flow from academia -> industry. Academia should recruit industry scientists at all levels and vice versa. Half of our lab has sig industry experience and it has transformed the way we approach questions.
  • user avatar
    Ansu Satpathy
    @Satpathology
    Apr 22, 2022
    Happy to share our study on CRISPR screens of T cell exhaustion! We find that targeting chromatin remodeling factors can improve T cell persistence and anti-tumor immunity. Awesome genomics + cancer IO work led by Julia Belk, Winnie Yao, Nghi Ly, and many terrific collaborators!
    user avatar
    bioRxiv
    @biorxivpreprint
    Apr 22, 2022
    Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence biorxiv.org/cgi/content/sh… #bioRxiv
  • user avatar
    Ansu Satpathy
    @Satpathology
    Jun 23, 2022
    Delighted to share our story out in @Cancer_Cell! Incredible amount of work led by Julia Belk and Winnie Yao, and wonderful collaborations with many close colleagues @SantoshVardhana @jccarnevale @MarsonLab @MackallLab
    Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit...
    From cell.com
  • user avatar
    Ansu Satpathy
    @Satpathology
    Feb 14, 2022
    Excited to announce that our lab is joining the Gladstone Institute of Genomic Immunology! Looking forward to teaming up with @Marsonlab to pursue the next generation of genomics-inspired immunotherapies and bridging @StanfordMed @parkerici and @Gladstone communities.
  • user avatar
    Ansu Satpathy
    @Satpathology
    May 27, 2022
    Our lab thinks a lot about the epigenetic regulation of T cell exhaustion. Happy to have a chance to discuss important prior work that has influenced our thinking as well as our own speculations in @NatImmunol. Led by Julia Belk and @BenceDaniel2
    Content cover image
    Epigenetic regulation of T cell exhaustion
    From nature.com
  • user avatar
    Ansu Satpathy
    @Satpathology
    Dec 16, 2018
    Excited to announce that I will be starting my lab in the Department of Pathology at Stanford! Now recruiting students and postdocs interested in studying cancer immunology with epigenomic and single-cell technologies! @StanfordPath @parkerici @CancerResearch #immunotherapy
  • user avatar
    Ansu Satpathy
    @Satpathology
    Oct 17, 2019
    Just got back from reviewing K08 applications @theNCI and thought I'd share some of my observations 1/
  • user avatar
    Ansu Satpathy
    @Satpathology
    Jul 25, 2025
    I am a strong believer that depth of data can be just as powerful as scale of data. Deep analysis of small groups of humans, and even individuals, can lead to novel biological insights and principles. Today I am the guinea pig. In my own blood, @CalebLareau finds strong evidence
    29K
  • user avatar
    Ansu Satpathy
    @Satpathology
    Nov 8, 2024
    Happy to share our new work describing DESynR genes! The evolution of new human protein-coding genes relies on repurposing protein domains from ancestral genes, rather than de novo sequence creation. New genes evolved from old parts, and while we have methods that enable
    25K
  • user avatar
    Ansu Satpathy
    @Satpathology
    Feb 9, 2025
    More than 2/3 of new medicines are created by biotech and in-licensed by pharma, and nearly every innovative biotech comes from academia. That’s because it takes years and years of sustained and consistent focus and perseverance on a basic biological problem to lead to innovative
    15K
  • user avatar
    Ansu Satpathy
    @Satpathology
    Jul 19, 2022
    Immunotherapies are only as effective as their targets. Excited to share the launch of Cartography Bio, focused on finding safe and effective antigens for every cancer patient. Wonderful to work with founders @krparker @HowardYChang @MaxMumbach @CalebLareau @JeffreyVerboon
    user avatar
    Cartography Biosciences
    @CartographyBio
    Jul 19, 2022
    We’re excited to officially launch Cartography Biosciences today with $57M in initial financing. With this support, we will create a smarter roadmap for #cancer immunotherapies with our precision antigen expression atlas. 🧵 #Oncology #MedTwitter businesswire.com/news/home/2022…
  • user avatar
    Ansu Satpathy
    @Satpathology
    Mar 12, 2025
    Happy to share our work in @natBME developing methods for non-viral intron engineering of CAR-T cells with large synthetic DNA sequences @ TheoRoth @parkerici
    Content cover image
    Non-viral intron knock-ins for targeted gene integration into human T cells and for T-cell selection
    From nature.com
    13K
  • user avatar
    Ansu Satpathy
    @Satpathology
    Sep 21, 2020
    Very happy to share our paper on CD19 expression in human brain mural cells! A wonderful collaboration with many people across institutions @krparker @HowardYChang @IAmDrDex @carlhjune @MiglioriniDenis and many others. @parkerici @CancerResearch @StanfordPath @PennMedicine
    user avatar
    Cell
    @CellCellPress
    Sep 21, 2020
    New Article online now at Cell: Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies zpr.io/HEnpB

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms of Service|Privacy Policy|Cookie Policy|Accessibility|Ads info|© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up